The transcriptional coactivator PGC-1α is dispensable for chronic overload-induced skeletal muscle hypertrophy and metabolic remodeling

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 50, 2013, Pages 20314-20319

  Pérez Schindler, Joaquín ^a   Summermatter, Serge ^a,d   Santos, Gesa ^a   Zorzato, Francesco ^b,c   Handschin, Christoph ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF FERRARA   (Italy)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Muscle overload; Resistance training; Transcriptional regulation

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENERGY METABOLISM; GENE DELETION; GENE EXPRESSION; GENE REPRESSION; METABOLIC REGULATION; METABOLIC REMODELING; MOUSE; MUSCLE CONTRACTILITY; MUSCLE HYPERTROPHY; NONHUMAN; PHENOTYPE; PLANTARIS MUSCLE; PRIORITY JOURNAL;

EID: 84890281516     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1312039110     Document Type: Article

References (43)

1. Egan B, Zierath JR (2013) Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab 17(2):162-184.
2. Glass D, Roubenoff R (2010) Recent advances in the biology and therapy of muscle wasting. Ann N Y Acad Sci 1211:25-36.
3. von Haehling S, Morley JE, Anker SD (2012) From muscle wasting to sarcopenia and myopenia: Update 2012. J Cachexia Sarcopenia Muscle 3(4):213-217.
4. Philp A, Hamilton DL, Baar K (2011) Signals mediating skeletal muscle remodeling by resistance exercise: PI3-kinase independent activation of mTORC1. J Appl Physiol (1985) 110(2):561-568.
5. Goodman CA, et al. (2011) The role of skeletal muscle mTOR in the regulation of mechanical load-induced growth. J Physiol 589(Pt 22):5485-5501.
6. Bentzinger CF, et al. (2013) Differential response of skeletal muscles to mTORC1 signaling during atrophy and hypertrophy. Skelet Muscle 3(1):6.
7. Schieke SM, et al. (2006) The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J Biol Chem 281(37):27643-27652.
8. Ramanathan A, Schreiber SL (2009) Direct control of mitochondrial function by mTOR. Proc Natl Acad Sci USA 106(52):22229-22232.
9. Düvel K, et al. (2010) Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell 39(2):171-183.
10. Cunningham JT, et al. (2007) mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 450(7170):736-740.
11. Chaveroux C, et al. (2013) Molecular and genetic crosstalks between mTOR and ERRα are key determinants of rapamycin-induced nonalcoholic fatty liver. Cell Metab 17(4):586-598.
12. Blättler SM, et al. (2012) Defective mitochondrial morphology and bioenergetic function in mice lacking the transcription factor Yin Yang 1 in skeletal muscle. Mol Cell Biol 32(16):3333-3346.
13. Schiaffino S, Dyar KA, Ciciliot S, Blaauw B, Sandri M (2013) Mechanisms regulating skeletal muscle growth and atrophy. FEBS J 280(17):4294-4314.
14. Brault JJ, Jespersen JG, Goldberg AL (2010) Peroxisome proliferator-activated receptor gamma coactivator 1alpha or 1beta overexpression inhibits muscle protein degradation, induction of ubiquitin ligases, and disuse atrophy. J Biol Chem 285(25):19460-19471.
15. Wenz T, Rossi SG, Rotundo RL, Spiegelman BM, Moraes CT (2009) Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging. Proc Natl Acad Sci USA 106(48):20405-20410.
16. Sandri M, et al. (2006) PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc Natl Acad Sci USA 103(44):16260-16265.
17. Ruas JL, et al. (2012) A PGC-1α isoform induced by resistance training regulates skeletal muscle hypertrophy. Cell 151(6):1319-1331.
18. Bodine SC, Baar K (2012) Analysis of skeletal muscle hypertrophy in models of increased loading. Methods Mol Biol 798:213-229.
19. Lowe DA, Alway SE (2002) Animal models for inducing muscle hypertrophy: Are they relevant for clinical applications in humans? J Orthop Sports Phys Ther 32(2):36-43.
20. Handschin C, Spiegelman BM (2011) PGC-1 coactivators and the regulation of skeletal muscle fiber-type determination. Cell Metab 13(4):351, author reply 352.
21. Handschin C, et al. (2007) Abnormal glucose homeostasis in skeletal muscle-specific PGC-1alpha knockout mice reveals skeletal muscle-pancreatic beta cell crosstalk. J Clin Invest 117(11):3463- 3474.
22. Lin J, et al. (2004) Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 119(1):121-135.
23. Hardie DG, Ross FA, Hawley SA (2012) AMPK: A nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 13(4):251-262.
24. Schiaffino S, Reggiani C (2011) Fiber types in mammalian skeletal muscles. Physiol Rev 91(4):1447-1531.
25. Drexler HC, et al. (2012) On marathons and Sprints: an integrated quantitative proteomics and transcriptomics analysis of differences between slow and fast muscle fibers. Mol Cell Proteomics 11(6):M111.010801.
26. Kamm KE, Stull JT (2011) Signaling to myosin regulatory light chain in sarcomeres. J Biol Chem 286(12):9941-9947.
27. Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149(2):274-293.
28. Romanino K, et al. (2011) Myopathy caused by mammalian target of rapamycin complex 1 (mTORC1) inactivation is not reversed by restoring mitochondrial function. Proc Natl Acad Sci USA 108(51):20808-20813.
29. Summermatter S, et al. (2012) Remodeling of calcium handling in skeletal muscle through PGC-1α: Impact on force, fatigability, and fiber type. Am J Physiol Cell Physiol 302(1):C88-C99.
30. Choi CS, et al. (2008) Paradoxical effects of increased expression of PGC-1alpha on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism. Proc Natl Acad Sci USA 105(50):19926-19931.
31. Handschin C, et al. (2007) Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1alpha muscle-specific knock-out animals. J Biol Chem 282(41):30014-30021.
32. Pérez-Schindler J, et al. (2012) The corepressor NCoR1 antagonizes PGC-1α and estrogen-related receptor α in the regulation of skeletal muscle function and oxidative metabolism. Mol Cell Biol 32(24):4913-4924.
33. Coffey VG, et al. (2006) Early signaling responses to divergent exercise stimuli in skeletal muscle from well-trained humans. FASEB J 20(1):190-192.
34. Item F, et al. (2013) Combined whole-body vibration, resistance exercise, and sustained vascular occlusion increases PGC-1α and VEGF mRNA abundances. Eur J Appl Physiol 113(4):1081-1090.
35. Donges CE, et al. (2012) Concurrent resistance and aerobic exercise stimulates both myofibrillar and mitochondrial protein synthesis in sedentary middle-aged men. J Appl Physiol (1985) 112(12):1992-2001.
36. Apró W, Wang L, Pontén M, Blomstrand E, Sahlin K (2013) Resistance exercise induced mTORC1 signaling is not impaired by subsequent endurance exercise in human skeletal muscle. Am J Physiol Endocrinol Metab 305(1):E22-E32.
37. Pérez-Schindler J, Handschin C (2013) New insights in the regulation of skeletal muscle PGC-1α by exercise and metabolic diseases. Drug Discov Today Dis Models 10(2):e79-e85.
38. Stepto NK, et al. (2009) Global gene expression in skeletal muscle from well-trained strength and endurance athletes. Med Sci Sports Exerc 41(3):546-565.
39. Liu D, et al. (2010) Skeletal muscle gene expression in response to resistance exercise: sex specific regulation. BMC Genomics 11:659.
40. Salvadego D, et al. (2013) Skeletal muscle oxidative function in vivo and ex vivo in athletes with marked hypertrophy from resistance training. J Appl Physiol (1985) 114(11):1527-1535.
41. Kandarian SC, White TP (1989) Force deficit during the onset of muscle hypertrophy. J Appl Physiol (1985) 67(6):2600-2607.
42. Kandarian SC, White TP (1990) Mechanical deficit persists during long-term muscle hypertrophy. J Appl Physiol (1985) 69(3):861-867.
43. McGee SL, Mustard KJ, Hardie DG, Baar K (2008) Normal hypertrophy accompanied by phosphoryation and activation of AMP-activated protein kinase alpha1 following overload in LKB1 knockout mice. J Physiol 586(6):1731-1741.